•
Sep 30, 2019

Arrowhead Pharmaceuticals Q4 2019 Earnings Report

Total Revenue
$43.3M
Previous year: $11.3M
+284.7%
EPS
$0.11
Previous year: -$0.12
-191.7%
Gross Profit
$43.3M
Previous year: $11.3M
+284.7%
Cash and Equivalents
$222M
Previous year: $30.1M
+636.1%
Free Cash Flow
$5.98M
Previous year: -$3.39M
-276.4%
Total Assets
$350M
Previous year: $112M
+213.5%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals